Literature DB >> 6601274

Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor.

F Fauvel, M E Grant, Y J Legrand, H Souchon, G Tobelem, D S Jackson, J P Caen.   

Abstract

Adult bovine aortic tissue was treated with 6 M guanidinium chloride in the presence of proteinase inhibitors to obtain an extract that was essentially devoid of collagenous components and appeared homogeneous by electron microscopy. When this extract was dispersed by sonication it was found to be a very potent inducer of human platelet aggregation. This interaction required the presence of von Willebrand factor and of its receptor (glycoprotein Ib) on platelet membrane. This was demonstrated by the fact that the aggregation of normal blood platelets resuspended in plasmas deficient in von Willebrand factor was significantly diminished as compared to aggregation in control plasma. Moreover, this aggregation was inhibited by a monoclonal antibody, IgG AN51, to platelet glycoprotein Ib. These studies provide direct biochemical evidence for the existence of a thrombogenic constituent of the vessel wall that is noncollagenous and von Willebrand factor-dependent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601274      PMCID: PMC393417          DOI: 10.1073/pnas.80.2.551

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Isolation and characterization of pepsin-treated type III collagen from calf skin.

Authors:  T Fujii; K Kühn
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1975-11

2.  Adhesion of platelets to subendothelium.

Authors:  H R Baumgartner; C Haudenschild
Journal:  Ann N Y Acad Sci       Date:  1972-10-27       Impact factor: 5.691

3.  Extraction and fractzonation of the media of the thoracic aorta: isolation and characterization of structural glycoproteins.

Authors:  M Moczar; L Robert
Journal:  Atherosclerosis       Date:  1970 Jan-Feb       Impact factor: 5.162

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Microfibrils (MF) platelet interaction: requirement of von Willebrand factor.

Authors:  Y J Legrand; F Fauvel; N Gutman; J P Muh; G Tobelem; H Souchon; A Karniguian; J P Caen
Journal:  Thromb Res       Date:  1980 Aug 15-Sep 1       Impact factor: 3.944

6.  Elastogenesis and microfibrillar glycoprotein synthesis by bovine ligamentum nuchae cells in culture.

Authors:  C H Sear; C J Jones; K R Knight; M E Grant
Journal:  Connect Tissue Res       Date:  1981       Impact factor: 3.417

7.  The identification of glycoproteins associated with elastic-tissue microfibrils.

Authors:  C H Sear; M A Kewley; C J Jones; M E Grant; D S Jackson
Journal:  Biochem J       Date:  1978-03-15       Impact factor: 3.857

8.  Isolation and partial characterization of basement membrane-like collagens from bovine thoracic aorta.

Authors:  R Mayne; J G Zettergren; P M Mayne; N W Bedwell
Journal:  Artery       Date:  1980

9.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

10.  Shape and functional properties of human platelets washed with acid citrate.

Authors:  H Patscheke
Journal:  Haemostasis       Date:  1981
View more
  11 in total

Review 1.  Platelet surface physiology and its importance in pharmacotherapy design and development: the adenosine diphosphate receptor antagonists.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

2.  Morphological relationships of von Willebrand factor, type VI collagen, and fibrillin in human vascular subendothelium.

Authors:  X X Wu; R E Gordon; R W Glanville; H J Kuo; R R Uson; J H Rand
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

3.  Characterization of an antibody directed against a 128 kDa glycoprotein involved in the thrombogenicity of the elastin-associated microfibrils.

Authors:  F Fauvel-Lafeve; P Picard; G Godeau; Y J Legrand
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

4.  150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.

Authors:  J H Rand; N D Patel; E Schwartz; S L Zhou; B J Potter
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 5.  The microfibril-associated glycoproteins (MAGPs) and the microfibrillar niche.

Authors:  Robert P Mecham; Mark A Gibson
Journal:  Matrix Biol       Date:  2015-05-08       Impact factor: 11.583

6.  Von Willebrand protein binds to extracellular matrices independently of collagen.

Authors:  D D Wagner; M Urban-Pickering; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury.

Authors:  Claudio C Werneck; Cristina P Vicente; Justin S Weinberg; Adrian Shifren; Richard A Pierce; Thomas J Broekelmann; Douglas M Tollefsen; Robert P Mecham
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113

8.  Characterization of a type VI collagen-related Mr-140 000 protein from cutis-laxa fibroblasts in culture.

Authors:  S W Crawford; J A Featherstone; K Holbrook; S L Yong; P Bornstein; H Sage
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

9.  Co-localization of von Willebrand factor and type VI collagen in human vascular subendothelium.

Authors:  J H Rand; X X Wu; B J Potter; R R Uson; R E Gordon
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

10.  Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion.

Authors:  V T Turitto; H J Weiss; H R Baumgartner
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.